JP2012521966A5 - - Google Patents

Download PDF

Info

Publication number
JP2012521966A5
JP2012521966A5 JP2011553339A JP2011553339A JP2012521966A5 JP 2012521966 A5 JP2012521966 A5 JP 2012521966A5 JP 2011553339 A JP2011553339 A JP 2011553339A JP 2011553339 A JP2011553339 A JP 2011553339A JP 2012521966 A5 JP2012521966 A5 JP 2012521966A5
Authority
JP
Japan
Prior art keywords
pain
urinary incontinence
epilepsy
mania
migraine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2011553339A
Other languages
English (en)
Japanese (ja)
Other versions
JP5727945B2 (ja
JP2012521966A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2010/001449 external-priority patent/WO2010102779A1/de
Publication of JP2012521966A publication Critical patent/JP2012521966A/ja
Publication of JP2012521966A5 publication Critical patent/JP2012521966A5/ja
Application granted granted Critical
Publication of JP5727945B2 publication Critical patent/JP5727945B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2011553339A 2009-03-10 2010-03-09 Kcnq2/3モジュレータとしての置換された3−アミノ−2−メルカプトキノリン Expired - Fee Related JP5727945B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP09003431 2009-03-10
EP09003431.5 2009-03-10
PCT/EP2010/001449 WO2010102779A1 (de) 2009-03-10 2010-03-09 Substituierte 3-amino-2-mercaptochinoline als kcnq2/3 modulatoren

Publications (3)

Publication Number Publication Date
JP2012521966A JP2012521966A (ja) 2012-09-20
JP2012521966A5 true JP2012521966A5 (enExample) 2014-10-16
JP5727945B2 JP5727945B2 (ja) 2015-06-03

Family

ID=40591941

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2011553339A Expired - Fee Related JP5727945B2 (ja) 2009-03-10 2010-03-09 Kcnq2/3モジュレータとしての置換された3−アミノ−2−メルカプトキノリン

Country Status (22)

Country Link
US (1) US8207342B2 (enExample)
EP (1) EP2406228B1 (enExample)
JP (1) JP5727945B2 (enExample)
KR (1) KR20110130461A (enExample)
CN (1) CN102341374A (enExample)
AR (1) AR075730A1 (enExample)
AU (1) AU2010223556B2 (enExample)
BR (1) BRPI1009519A2 (enExample)
CA (1) CA2754943A1 (enExample)
CL (1) CL2011002160A1 (enExample)
CO (1) CO6410291A2 (enExample)
EC (1) ECSP11011346A (enExample)
ES (1) ES2436365T3 (enExample)
IL (1) IL214944A0 (enExample)
MX (1) MX2011009338A (enExample)
NZ (1) NZ595569A (enExample)
PE (1) PE20120535A1 (enExample)
PL (1) PL2406228T3 (enExample)
RU (1) RU2011140701A (enExample)
TW (1) TWI504395B (enExample)
WO (1) WO2010102779A1 (enExample)
ZA (1) ZA201107370B (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2012520246A (ja) * 2009-03-10 2012-09-06 グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング Kcnq2/3モジュレータとしての置換された3−アミノイソオキサゾロピリジン
TW201038565A (en) 2009-03-12 2010-11-01 Gruenenthal Gmbh Substituted 2-mercapto-3-aminopyridines as KCNQ2/3 modulators
TWI461197B (zh) 2009-03-12 2014-11-21 2-mercaptoquinoline-3-carboxamide as a KCNQ2 / 3 modifier
TWI475020B (zh) 2009-03-12 2015-03-01 The substituted nicotine amide as a KCNQ2 / 3 modifier
PL2609086T3 (pl) 2010-08-27 2015-07-31 Gruenenthal Gmbh Podstawione 2-okso- i 2-tiookso-dihydrochinolino-3-karboksyamidy jako modulatory KCNQ2/3
MX2013000748A (es) 2010-08-27 2013-03-05 Gruenenthal Gmbh 2-amino-quinolina-3-carboxamidas sustituidas como moduladores de kcnq2/3.
KR20130100300A (ko) 2010-08-27 2013-09-10 그뤼넨탈 게엠베하 Kcnq2/3 조절제로서의 치환된 2-옥시-퀴놀린-3-카복스아미드
BR112013005056A2 (pt) 2010-09-01 2016-05-31 Gruenenthal Gmbh 1-oxo-di-hidroisoquinolina-3-carboxamidas substituídas como moduladores kcnq2/3
DE102018212006B3 (de) * 2018-07-18 2019-10-31 Universität Greifswald Thioether als Modulatoren von Kv7.2/Kv7.3-Kanälen

Family Cites Families (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2706977A1 (de) 1977-02-18 1978-08-24 Hoechst Ag Benzoesaeuren und deren derivate sowie verfahren zu ihrer herstellung
FR2532939A1 (fr) 1982-09-13 1984-03-16 Roussel Uclaf Nouveaux derives de l'acide 4-hydroxy 3-quinoleine carboxylique substitues en 2, leur preparation, leur application comme medicament, les compositions les renfermant et les nouveaux intermediaires obtenus
DE4032147A1 (de) 1990-10-10 1992-04-16 Bayer Ag Verwendung von substituierten 2-mercaptonicotinsaeurederivaten zur bekaempfung von endoparasiten, neue substituierte 2-mercaptonicotinsaeurederivate und verfahren zu ihrer herstellung
US5583147A (en) * 1994-03-23 1996-12-10 The Dupont Merck Pharmaceutical Company Amides for the treatment of atherosclerosis
EP0716077A1 (de) 1994-12-08 1996-06-12 Ciba-Geigy Ag Aromatisch substituierte Omega-Aminoalkansäureamide und Alkansäurediamide und ihre Verwendung als Renininhibitoren
WO1996026925A1 (en) 1995-03-01 1996-09-06 Banyu Pharmaceutical Co., Ltd. Arylthioacetamide derivatives
JP2001513560A (ja) * 1997-08-28 2001-09-04 ブリストル−マイヤーズ スクイブ カンパニー 4−アリール−3−アミノキノリン−2−オン誘導体カリウムチャンネル調節剤
DE19738616A1 (de) 1997-09-04 1999-03-11 Clariant Gmbh 4-Hydroxychinolin-3-carbonsäure-Derivate als Lichtschutzmittel
AU3033500A (en) 1999-01-15 2000-08-01 Agouron Pharmaceuticals, Inc. Non-peptide glp-1 agonists
EP1200086A4 (en) 1999-08-04 2009-05-27 Icagen Inc THERAPEUTIC OR PROPHYLACTIC METHODS OF PAIN AND ANXIETY
EP1208085B1 (en) 1999-08-04 2007-12-05 Icagen, Inc. Benzanilides as potassium channel openers
CZ20032233A3 (cs) 2001-02-20 2004-12-15 Bristol-Myers Squibb Company Derivát 2,4-disubstituovaného pyrimidin-5-karboxamidu jako modulátor draslíkového kanálku KCNQ
MXPA03007397A (es) 2001-02-20 2003-12-04 Bristol Myers Squibb Co Moduladores de canales de potasio kcnq y uso de los mismos en tratamiento de migrana y enfermedades mecanicamente relacionadas.
US6593349B2 (en) 2001-03-19 2003-07-15 Icagen, Inc. Bisarylamines as potassium channel openers
AU2002256085A1 (en) 2001-04-06 2002-10-21 Smithkline Beecham Corporation Quinoline inhibitors of hyak1 and hyak3 kinases
US20040110947A1 (en) 2002-09-17 2004-06-10 Pharmacia Corporation Aromatic liver X-receptor modulators
CA2505195C (en) * 2002-12-23 2012-07-10 Icagen, Inc. Quinazolinones as potassium channel modulators
EP1449841A1 (en) 2003-02-19 2004-08-25 Bayer CropScience SA New fungicidal compounds
US7598412B2 (en) 2003-10-08 2009-10-06 Vertex Pharmaceuticals Incorporated Modulators of ATP-binding cassette transporters
KR20070006890A (ko) 2004-05-04 2007-01-11 화이자 인코포레이티드 오르토 치환된 아릴 또는 헤테로아릴 아마이드 화합물
EP1814856A1 (en) 2004-11-12 2007-08-08 Galapagos N.V. Nitrogen heteroaromatic compounds which bind to the active site of protein kinase enzymes
CA2599890C (en) 2005-03-03 2011-05-03 H. Lundbeck A/S Substituted pyridine derivatives
DE102005038947A1 (de) 2005-05-18 2006-11-30 Grünenthal GmbH Substituierte Benzo[d]isoxazol-3-yl-amin-Verbindungen und deren Verwendung in Arzneimitteln
US8133907B2 (en) 2005-07-20 2012-03-13 Eli Lilly And Company Pyridine derivatives as dipeptedyl peptidase inhibitors
US7915410B2 (en) 2005-09-09 2011-03-29 Bristol-Myers Squibb Company Acyclic IKur inhibitors
EP1951685A1 (en) * 2005-11-18 2008-08-06 NeuroSearch A/S Novel quinazoline derivatives and their medical use
DE602007004638D1 (de) 2006-07-20 2010-03-18 Amgen Inc Benzoädüisoxazol-derivate als c-kit-tyrosinkinase-hemmer zur behandlung von erkrankungen im zusammenhang mit der überproduktion von histamin
CA2658190C (en) 2006-07-20 2013-01-29 Amgen Inc. Di-amino-substituted heterocyclic compounds and methods of use
WO2008012532A2 (en) 2006-07-27 2008-01-31 Astrazeneca Ab : pyridine-3-carboxamide compounds and their use for inhibiting 11-beta-hydroxysteroid dehydrogenase
DE102006049452A1 (de) 2006-10-17 2008-05-08 Grünenthal GmbH Substituierte Tetrahydropyrolopiperazin-Verbindungen und deren Verwendung in Arzneimitteln
US8563566B2 (en) 2007-08-01 2013-10-22 Valeant Pharmaceuticals International Naphthyridine derivatives as potassium channel modulators
CA2695331A1 (en) 2007-08-03 2009-02-12 F. Hoffmann-La Roche Ag Pyridinecarboxamide and benzamide derivatives as taar1 ligands
WO2009052078A1 (en) 2007-10-19 2009-04-23 Boehringer Ingelheim International Gmbh Ccr10 antagonists
JP2012520246A (ja) 2009-03-10 2012-09-06 グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング Kcnq2/3モジュレータとしての置換された3−アミノイソオキサゾロピリジン
TWI475020B (zh) 2009-03-12 2015-03-01 The substituted nicotine amide as a KCNQ2 / 3 modifier
TWI461197B (zh) 2009-03-12 2014-11-21 2-mercaptoquinoline-3-carboxamide as a KCNQ2 / 3 modifier
TW201038565A (en) 2009-03-12 2010-11-01 Gruenenthal Gmbh Substituted 2-mercapto-3-aminopyridines as KCNQ2/3 modulators

Similar Documents

Publication Publication Date Title
JP2012520249A5 (enExample)
JP2018513107A5 (enExample)
JP2015535270A5 (enExample)
JP2009510044A5 (enExample)
JP2014506321A5 (enExample)
JP2009504622A5 (enExample)
JP2009533356A5 (enExample)
MY167423A (en) Quinoline carboxamide and quinoline carbonitrile derivatives as mglur2-negative allosteric modulators,compositions,and their use
NZ591326A (en) An extended release pharmaceutical composition of entacapone or salts thereof
EA201891374A1 (ru) Замещенные 2-фенил-3-(пиперазинметил)имидазопиридины и их применение
EA201390827A1 (ru) Применение лаквинимода для уменьшения утомляемости, улучшения функционального состояния и улучшения качества жизни пациентов с рассеянным склерозом
RU2018138183A (ru) Оксистеролы и способы их применения
MD4369B1 (ro) Utilizarea glicopirolatului pentru tratarea tahicardiei, doză unică, dispozitiv de administrare, metodă de tratament şi profilaxie a tahicardiei
NZ595569A (en) Substituted 3-amino-2-mercaptoquinolines as kcnq2/3 modulators
JP2013516475A5 (enExample)
WO2017119456A1 (ja) せん妄の予防または治療剤
Khasanov et al. Optimization of the diagnosis of ronchopathy in patients with diseases of ent-organs
CL2014001046A1 (es) Proceso de preparacion de compuestos derivados de acilguanidinas y aciltioureas, utiles para el tratamiento de enfermedades de los pulmones y de las vias respiratorias; y compuestos intermediarios utilizados en dicho proceso.
WO2012038850A8 (en) Pyrimidones for treatment of potassium channel related diseases
HRP20160832T1 (hr) Liječenje osteoporoze
JP2010195697A5 (enExample)
Han et al. A retrospective study of 54 cases with chronic otitis media prepared for staging tympanoplasty
Berg et al. Gynecological Consequences of Female Genital Mutilation/Cutting (FGM/C)[Internet]
FR2927256B1 (fr) Composition pour le traitement des affections inflammatoires des voies respiratoires a base d'une alfa-amylase et d'un anesthesique local et son procede de preparation
Oles et al. A case of respiratory epithelial adenomatoid hamartoma of the sinonasal tract